Literature DB >> 9698599

Overproduction of the CFTR R domain leads to increased levels of asialoGM1 and increased Pseudomonas aeruginosa binding by epithelial cells.

R Bryan1, D Kube, A Perez, P Davis, A Prince.   

Abstract

Mutations in cystic fibrosis transmembrane conductance regulator (CFTR), particularly the common DeltaF508 mutation, have been associated with alterations in glycolipid sialylation and the availability of receptors for Pseudomonas aeruginosa binding. The surface properties of 9HTEo- tracheal epithelial cell lines transfected with plasmids that overproduce the regulatory (R) domain of CFTR (pCEP-R) and lack cyclic adenosine monophosphate-stimulated Cl- conductance were compared with control cell lines with normal CFTR function. There was increased bacterial adherence to the mutant cell lines with abnormal CFTR activity. Cell lines with overexpression of the R domain had surface properties similar to cells expressing the common DeltaF508 mutation in CF. P. aeruginosa adherence correlated with the increased numbers of asialoGM1 residues available on the surface of the epithelial cells with altered CFTR function; and antibody to asialoGM1, a P. aeruginosa pilin receptor, was able to compete with piliated bacteria for epithelial binding sites. The pCEP-R cell lines with increased bacterial binding were also associated with increased production of interleukin-8 in response to adherent P. aeruginosa compared with cells transfected with the empty vector pCEP. P. aeruginosa pil mutants that lack the adhesin specific for the asialoGM1 receptor did not discriminate between epithelial cells with normal or deficient CFTR function. These results confirm a direct relationship between aberrant CFTR function and increased levels of apical asialoGM1, and support the role of these asialylated glycolipids as P. aeruginosa receptors that initiate an epithelial proinflammatory response in response to bacterial ligands.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9698599     DOI: 10.1165/ajrcmb.19.2.2889

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  25 in total

1.  In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium.

Authors:  T J Kelley; H L Elmer
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Human airway epithelia express catalytically active NEU3 sialidase.

Authors:  Erik P Lillehoj; Sang Won Hyun; Chiguang Feng; Lei Zhang; Anguo Liu; Wei Guang; Chinh Nguyen; Wenji Sun; Irina G Luzina; Tonya J Webb; Sergei P Atamas; Antonino Passaniti; William S Twaddell; Adam C Puché; Lai-Xi Wang; Alan S Cross; Simeon E Goldblum
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-03-21       Impact factor: 5.464

3.  Lack of adherence of clinical isolates of Pseudomonas aeruginosa to asialo-GM(1) on epithelial cells.

Authors:  T H Schroeder; T Zaidi; G B Pier
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 4.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

5.  Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung.

Authors:  J F Poschet; J C Boucher; L Tatterson; J Skidmore; R W Van Dyke; V Deretic
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

6.  Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone inhibits expression of P2Y receptors in cystic fibrosis tracheal gland cells.

Authors:  A Saleh; C Figarella; W Kammouni; S Marchand-Pinatel; A Lazdunski; A Tubul; P Brun; M D Merten
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection.

Authors:  Moayad Alhariri; Abdelwahab Omri
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

8.  Terminal glycosylation of cystic fibrosis airway epithelial cells.

Authors:  A D Rhim; V A Kothari; P J Park; A E Mulberg; M C Glick; T F Scanlin
Journal:  Glycoconj J       Date:  2000-06       Impact factor: 2.916

Review 9.  The role of inflammation in the pathophysiology of CF lung disease.

Authors:  James F Chmiel; Melvin Berger; Michael W Konstan
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

10.  Modulation of cystic fibrosis lung disease by variants in interleukin-8.

Authors:  A D Hillian; D Londono; J M Dunn; K A B Goddard; R G Pace; M R Knowles; M L Drumm
Journal:  Genes Immun       Date:  2008-06-19       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.